Seoul Pharma Co. Ltd (018680) — Capital Reinvestment Ratio
Latest as of June 2025:
0.04x
Seoul Pharma Co. Ltd (018680) has a Capital Reinvestment Ratio of 0.04x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩2.07 Billion) in capital expenditures (₩89.75 Million). See 018680 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.07 Billion
KRW
Capital Expenditures
₩89.75 Million
KRW
Data as of
Jun 2025
Most recent filing
Seoul Pharma Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks Seoul Pharma Co. Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for Seoul Pharma Co. Ltd from 2009 to 2023. For live market cap and broader valuation context, see market value of Seoul Pharma Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.36x | ₩5.26 Billion | ₩1.89 Billion | ▲ +207.5% |
| 2020 | 0.12x | ₩5.74 Billion | ₩671.25 Million | ▲ +119.1% |
| 2019 | 0.05x | ₩2.93 Billion | ₩156.43 Million | ▼ -94.6% |
| 2015 | 0.98x | ₩1.42 Billion | ₩1.40 Billion | ▼ -44.5% |
| 2014 | 1.77x | ₩1.48 Billion | ₩2.62 Billion | ▼ -9.0% |
| 2012 | 1.95x | ₩9.22 Billion | ₩17.95 Billion | ▲ +74.2% |
| 2011 | 1.12x | ₩4.86 Billion | ₩5.43 Billion | ▼ -77.4% |
| 2009 | 4.95x | ₩1.23 Billion | ₩6.11 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow